Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$55.06 - $69.99 $204,382 - $259,802
3,712 New
3,712 $208,000
Q2 2023

Jul 27, 2023

SELL
$46.28 - $75.01 $211,545 - $342,870
-4,571 Reduced 55.19%
3,712 $256,000
Q1 2023

May 11, 2023

BUY
$43.42 - $57.37 $28,526 - $37,692
657 Added 8.62%
8,283 $399,000
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $295,888 - $422,937
7,626 New
7,626 $380,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.